Office of Academic Resources
Chulalongkorn University
Chulalongkorn University

Home / Help

Title33rd Hemophilia Symposium [electronic resource] : Hamburg 2002 / edited by Inge Scharrer, Wolfgang Schramm
ImprintBerlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2004
Connect tohttp://dx.doi.org/10.1007/978-3-642-18260-0
Descript XXXII, 308 p. online resource

CONTENT

HIV Infection and Causes of Death in Patients with Hemophilia in Germany (Year 2001/2002 Survey) -- Hemophilia Registry of the Medical Committee of the Swiss Hemophilia Association โ{128}{148} Annual Survey 2002 -- ยปNew Virusesยซ and the Safety of Factor Concentrates and Stable Blood Products: TT Virus and West Nile Virus as Current Examples -- A Retrospective Study on the Development of Inhibitors after Continuous Infusion of Factor VIII -- Characterization of Factor VIII-Inhibitory Antibodies Using Phage Display -- Rituximab โ{128}{148} A new Treatment of Acquired Hemophilia A? -- Thrombin Generation and Thrombogram: Assays for Monitoring Factor VIII Bypassing Therapies -- Rehabilitation โ{128}{148} A Topic for Hemophiliacs? -- Functional Analysis as a Basis for Optimizing Physiotherapy in Hemophilic Children -- Sport and Physical Fitness Recommendations for Young Hemophiliacs -- Pain Versus Clinical and Radiological Assessment in Hemophilic Arthropathies -- Endogenous Thrombin Potential in Platelet-Rich Plasma โ{128}{148} New Insights Regarding the Different Action of F VIII and F IX -- Interactive and Case-Based Training of Diagnostic Skills and Therapeutical Management of Coagulation Disorders with CAMPUS, a Computer-Based Program -- Elevated Fibrinogen is a Risk Factor for Arterial Thrombosis in Children -- Increased von-Willebrand-Factor-Binding to Platelets in Neonatal Plasma -- Neonatal Protein C Deficiency after massive thromboembolic Event of the right upper Limb Treatment with Protein C Concentrate -- IMMUNATE S/D โ{128}{148} A new Factor VIII โ{128}{148} von-Willebrand-Factor Complex Concentrate -- Favorable Response to Protein C in Venoocclusive Disease after Allogeneous Stem Cell Transplantation -- Phase III Clinical Evaluation of rAHF-PFM Prepared Using a Plasma/Albumin free Method -- Anti-Prionin IgG, Possible new Serum Markers for Contact and Infection with Transmissible Spongiform Encephalopathies: Preliminary Results from Screening 100 Blood Donors -- Experimental Approaches to Hemophilia Gene Therapy: Gene Transfer into Hematopoietic Stem Cells -- Von-Willebrand-Factor Cleaving Protease (ADAMTS-13) Activity in Various Thrombotic, Hemolytic and Autoimmune Disorders -- Treatment with Interferon Alpha-2a in Patients with Hepatitis C and Hemophilia -- Practical Experiences with Therapies for Chronic Hepatitis C in Hemophilia Patients -- Deep Venous Thrombosis of the Lower Extremity in a 16-Year-old Girl with Homozygous MTHFR- and Heterozygous Factor V Leiden-Mutation -- Clinical Manifestations of Patients with Highly Elevated Anticardiolipin Antibodies -- Progression of an Extensive Deep Vein Thrombosis Under High Dose Therapy with low Molecular Weight Heparin of a 13-4 Year-old Girl Suffering from Colitis Ulcerosa -- Hyperfibrinolysis in Hemophagocytic Lymphohistiocytosis -- Prolonged Lysis-Therapy of an Arteria Iliaca Externa Thrombosis in a very low Birth Weight Infant with a Variant in the Factor-XIII-Gene -- Modified Immunsuppression in a Case of Acquired Hemophilia โ{128}{148} Case Report -- Life-Threatening Bleeding after Vaccination as a First Manifestation of Hemophilia A -- Administration of Protein C-Concentrate (Ceprotin, Baxter) in Purpura Fulminans as the First Clinical Manifestation of Galactosemia -- Case Report: Successful Treatment of a Spontaneous Acquired Inhibitor against Factor VIII in a 73-Year old Patient -- Medical Need and Quality of Life in Patients with Hemophilia A -- Quality of Life Autoevaluation of Hemophilia Patients in Romania -- Valproate-Induced Type I von-Willebrandโ{128}{153}s Disease โ{128}{148} a Common Occurrence? -- Bleeding Symptoms in Carriers of Hemophilia A โ{128}{148} Association to the Factor VIII Gene Mutation? -- Recombinant Human Interferon ?-2b Therapy, for Refractory Immune Thrombocytopenic Purpura in Children -- Review on Bleeding Episodes in Hemophiliacs Receiving no Primary Prophylactic Replacement Therapy -- Endogenous Thrombin Potential and Thrombin Activatable Fibrinolysis Inhibitor in Patients with Hemophilia and von-Willebrand Disease -- Different Thrombotic Risk Factors โ{128}{148} Contribution to the Endogenous Thrombin Potential -- Coagulation Parameters in Pregnancy: Low-Molecular-Weight Heparin Prophylaxis in Women with Thrombophilic Risk Factors -- Malignancy is not Associated with Decreased ADAMTS-13 Activity in Patients with Brain Tumors -- Analysis of Factor VIII RNA from Hemophilia A Patients with no Detectable Mutation in the Coding Regions -- FISH for Carrier Detection of Large Deletions in the Factor VIII Gene -- Homozygosity Mapping of a Second Gene Locus for Hereditary Combined Deficiency of Vitamin-K-Dependent Clotting Factors (FMFD) to Chromosome 16 -- First Case of Compound Heterozygosity in the Gamma-Glutamyl Carboxylase Gene Causing Combined Deficiency of all Vitamin-K-Dependent Blood Coagulation Factors -- Phosphatidylserine in the Neonatal and Adult Platelet Membrane: A Comparison -- Low Protein C, Tissue Factor Pathway Inhibitor, and Antithrombin Allow Sufficient Thrombin Generation in Neonatal Plasma


Medicine Anesthesiology Critical care medicine Blood transfusion Hematology Pediatrics Medicine & Public Health Hematology Anesthesiology Intensive / Critical Care Medicine Blood Transfusion Medicine Pediatrics



Location



Office of Academic Resources, Chulalongkorn University, Phayathai Rd. Pathumwan Bangkok 10330 Thailand

Contact Us

Tel. 0-2218-2929,
0-2218-2927 (Library Service)
0-2218-2903 (Administrative Division)
Fax. 0-2215-3617, 0-2218-2907

Social Network

  line

facebook   instragram